52 related articles for article (PubMed ID: 18719345)
1. Therapeutic aspects of hepatitis C in hemodialysis patients.
Hosseini Moghaddam SM; Alavian SM; Rahnavardi M
Am J Nephrol; 2009; 29(2):123-8. PubMed ID: 18719345
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C in dialysed patients--what is the current optimal treatment?
Kes P; Basic-Jukic N
Kidney Blood Press Res; 2007; 30(3):156-61. PubMed ID: 17446715
[TBL] [Abstract][Full Text] [Related]
3. Treatment of HCV in patients with renal failure.
Kalia H; Lopez PM; Martin P
Arch Med Res; 2007 Aug; 38(6):628-33. PubMed ID: 17613354
[TBL] [Abstract][Full Text] [Related]
4. Is {beta}-interferon a promising therapeutic option for the management of hepatitis C?
Hosseini-Moghaddam SM; Mousavi A; Alavian SM
J Antimicrob Chemother; 2009 Jun; 63(6):1097-103. PubMed ID: 19329508
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic viral hepatitis in patients with renal disease.
Fabrizi F; Martin P; Bunnapradist S
Gastroenterol Clin North Am; 2004 Sep; 33(3):655-70, xi. PubMed ID: 15324949
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis C in patients with renal disease.
Gane E
Med J Malaysia; 2005 Jul; 60 Suppl B():72-6. PubMed ID: 16108179
[No Abstract] [Full Text] [Related]
7. HCV in patients with end-stage renal disease.
Okoh EJ; Bucci JR; Simon JF; Harrison SA
Am J Gastroenterol; 2008 Aug; 103(8):2123-34. PubMed ID: 18796105
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of human natural beta-interferon in patients with end-stage renal failure.
Nakayama H; Shiotani S; Akiyama S; Gotoh H; Tani M; Akine Y
Clin Nephrol; 2001 Nov; 56(5):382-6. PubMed ID: 11758009
[TBL] [Abstract][Full Text] [Related]
10. A chronic HCV positive hemodialysis patient with an unusual treatment complication.
Mousa D; Altayeb A
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):282-6. PubMed ID: 17612040
[No Abstract] [Full Text] [Related]
11. New drugs for hepatitis C virus.
Pockros PJ
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):145-54. PubMed ID: 19072442
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C infection and chronic renal diseases.
Perico N; Cattaneo D; Bikbov B; Remuzzi G
Clin J Am Soc Nephrol; 2009 Jan; 4(1):207-20. PubMed ID: 19129320
[TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
14. Interferon-based therapy for dialysis patients with chronic hepatitis C: progress and challenges.
Liu CH; Liu CJ; Kao JH
Nephrology (Carlton); 2007 Feb; 12(1):8-10. PubMed ID: 17295654
[No Abstract] [Full Text] [Related]
15. Hemodialysis patients with hepatitis C infection are not receiving the new antiviral medications.
Goodkin DA; Bieber B
Am J Nephrol; 2015; 41(4-5):302. PubMed ID: 26044708
[No Abstract] [Full Text] [Related]
16. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
17. Nutritional status of hemodialysis patients with hepatitis C infection.
Chong VH
Ren Fail; 2007; 29(6):773. PubMed ID: 17763178
[No Abstract] [Full Text] [Related]
18. Management of Chronic Hepatitis C in End-stage Renal Disease.
Angulo-Diaz V; Lim JK; Martin P; Liapakis A
J Clin Gastroenterol; 2018 Apr; 52(4):287-294. PubMed ID: 29099465
[TBL] [Abstract][Full Text] [Related]
19. Comment on "Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience".
Li X; Lou L
Rev Assoc Med Bras (1992); 2021 Jun; 67(6):909. PubMed ID: 34709345
[No Abstract] [Full Text] [Related]
20. Kidney Transplants for Patients With Hepatitis C Virus Infection.
Ann Intern Med; 2018 Aug; 169(4):. PubMed ID: 29987320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
